ExoXpert is offering the ExoPulse platform to its clients. The platform is already authorized by EU regulators for clinical trials (phase I/II).

By accessing ExoPulse, our partners can derisk the challenge of building their own manufacturing process for GMP compliant exosomes. Furthermore, the platform allows production of exosomes which is key for supplying clinical trials needs in an affordable way.

In addition, the ExoPulse platform offers a module load RNA into exosomes in a full GMP compliant way.